China's Pediatric Flu Drug Pipeline Gets Another Boost: Onradivir Granules NDA Accepted
May 18, 2026 14:55
CST Updated
May 19, 10:43
Zhongsheng Pharmaceutical
Pharmaceutical R&D and Manufacturer
Simcere
Innovative Drug Developer